Image pharmaphorum Editor Market Access Pharma’s post-pandemic launch performance problem: what’s th... The prescription medicine market has recovered from the wild swings of the early pandemic with renewed growth. Market Access Six months after authorization, what do we know about Paxlov... It has now been over six months since the Views & Analysis How digital is transforming the commercial leader’s role in ... Pharma’s evolving role in patient care Digital Sponsored Artificial intelligence in medicine Thanks to constant advances in technology and science, artificial intelligence (AI) is rapidly becoming an integral part of modern healthcare. Load more results
Market Access Pharma’s post-pandemic launch performance problem: what’s th... The prescription medicine market has recovered from the wild swings of the early pandemic with renewed growth.
Market Access Six months after authorization, what do we know about Paxlov... It has now been over six months since the
Views & Analysis How digital is transforming the commercial leader’s role in ... Pharma’s evolving role in patient care
Digital Sponsored Artificial intelligence in medicine Thanks to constant advances in technology and science, artificial intelligence (AI) is rapidly becoming an integral part of modern healthcare.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
